Ladislav Andera
Prague, PR, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Determination of ADP/ATP translocase isoform ratios in malignancy and cellular senescence.
Journal: Molecular oncology
Published: December 11, 2024
Long-term adaptation of lymphoma cell lines to hypoxia is mediated by diverse molecular mechanisms that are targetable with specific inhibitors.
Journal: Cell death discovery
Published: August 05, 2024
Cell-specific modulation of mitochondrial respiration and metabolism by the pro-apoptotic Bcl-2 family members Bax and Bak.
Journal: Apoptosis : an international journal on programmed cell death
Published: October 29, 2023
Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion.
Journal: Experimental hematology & oncology
Published: September 01, 2023
MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colorectal cancer patients.
Journal: Frontiers in oncology
Published: June 01, 2022
Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells.
Journal: Aging
Published: April 21, 2022
BH3 Mimetics in Hematologic Malignancies.
Journal: International journal of molecular sciences
Published: August 30, 2021
Simultaneous targeting of mitochondrial metabolism and immune checkpoints as a new strategy for renal cancer therapy.
Journal: Clinical and translational medicine
Published: June 14, 2021
Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas.
Journal: Molecular cancer therapeutics
Published: June 09, 2021
The Interactions of DNA Repair, Telomere Homeostasis, and p53 Mutational Status in Solid Cancers: Risk, Prognosis, and Prediction.
Journal: Cancers
Published: December 06, 2020
Last Updated: 09/26/2026